Technical Analysis for CDNA - CareDx, Inc.

Grade Last Price % Change Price Change
grade C 26.67 6.85% 1.71
CDNA closed up 6.85 percent on Friday, February 14, 2020, on 67 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
Earnings due: Feb 27
*** please verify all earnings dates ***

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Flat Up Up
Historical CDNA trend table...

Date Alert Name Type % Chg
Expansion Breakout Bullish Swing Setup 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Stochastic Reached Overbought Strength 6.85%
Overbought Stochastic Strength 6.85%
Up 3 Days in a Row Strength 6.17%
20 DMA Support Bullish 7.28%
Hammer Candlestick Bullish 7.28%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 7.28%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

CareDx, Inc. develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime. It provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection at the time of testing in conjunction with standard clinical assessment. The company also offers AlloMap Molecular Expression Testing, an in vitro diagnostic multivariate index assay test service performed in a single laboratory assessing the gene expression profile of RNA isolated from peripheral blood mononuclear cells. It markets and sells its products through distribution partners in the United States, Canada, and Europe. CareDx, Inc. was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in April 2014. The company was incorporated in 1998 and is based in Brisbane, California.
Medicine Medical Specialties Clinical Medicine Gene Expression Organ Transplantation Transplantation Medicine

Is CDNA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 41.27
52 Week Low 18.75
Average Volume 697,347
200-Day Moving Average 26.76
50-Day Moving Average 22.58
20-Day Moving Average 24.05
10-Day Moving Average 24.97
Average True Range 1.06
ADX 22.04
+DI 35.03
-DI 15.79
Chandelier Exit (Long, 3 ATRs ) 23.55
Chandelier Exit (Short, 3 ATRs ) 24.34
Upper Bollinger Band 26.58
Lower Bollinger Band 21.52
Percent B (%b) 1.02
BandWidth 21.05
MACD Line 0.91
MACD Signal Line 0.78
MACD Histogram 0.1312
Fundamentals Value
Market Cap 601.16 Million
Num Shares 22.5 Million
EPS -1.39
Price-to-Earnings (P/E) Ratio -19.19
Price-to-Sales 2.74
Price-to-Book 10.33
PEG Ratio -0.35
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 29.42
Resistance 3 (R3) 29.13 27.94 28.96
Resistance 2 (R2) 27.94 27.24 28.08 28.80
Resistance 1 (R1) 27.30 26.81 27.62 27.59 28.65
Pivot Point 26.11 26.11 26.27 26.25 26.11
Support 1 (S1) 25.47 25.41 25.79 25.76 24.69
Support 2 (S2) 24.28 24.98 24.42 24.54
Support 3 (S3) 23.64 24.28 24.38
Support 4 (S4) 23.93